Stephen L. Silvestro

Stephen L. Silvestro is the Chief Executive Officer of OptimizeRx Corporation and is 47 years old as of March 20, 2025. " " " He has a strong academic background, holding a Master of Liberal Arts in Business Management from Harvard University and a Bachelor of Arts in Italian and Business Management from Brigham Young University. " "

Before joining OptimizeRx, he built an impressive career with roles at CCH® Tagetik, Prognos Health, Inc., and Decision Resources Group, where he advanced his expertise in global sales and commercial operations. " " "

At OptimizeRx, he began his tenure as Chief Commercial Officer on April 29, 2019, was later promoted to President in October 2023, and then served as Interim CEO in January 2025, before officially assuming the role of CEO on March 10, 2025. " " "

His career reflects a dedication to strategic leadership and operational excellence, making significant contributions to the company’s evolution and long-term growth. "

Non-Equity Incentive Plan Compensation

• Performance Metrics:
  • Revenue: 50% weighting
  • Adjusted EBITDA: 50% weighting "
• Payout Structure:
  • Threshold: Payout of 50% of the target if met
  • Target: Set higher than the Company’s financial guidance
  • Maximum: Cap at 200% of the target annual incentive opportunity
• Target Annual Incentive Opportunity: 60% of base salary for Stephen L. Silvestro "
• Vesting & Payment: Paid annually after the fiscal year; no vesting schedule applies " "
• Evaluation Period: Fiscal 2024

Annual Incentive Awards

• Performance Metrics:
  • Revenue: 50% weight
  • Adjusted EBITDA: 50% weight "
• Payout Details:
  • Threshold Level: No payout if not met
  • Payout at Threshold: 50% of target
  • Maximum Award Level: 200% of the target incentive opportunity
• Target Award for Stephen L. Silvestro: 60% of base salary "
• Additional Notes:
  • Exact performance achievement levels (threshold, target, and maximum) are not numerically specified in the documents "

This summarizes the performance-based compensation details provided for fiscal 2024. " "